CAMILLE BUCHMILLER: Open Payments
NPI 1194092890 · NAMPA, ID. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$270 in 4 payments from 3 companies in 2025. Trend: 2023 $619 · 2024 $1,108 · 2025 $270
Food & beverage: $270
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 1 | $123 |
| GlaxoSmithKline, LLC. | 1 | $94 |
| Insmed, Inc. | 2 | $53 |
Products named: AIRSUPRA, NUCALA, Arikayce.
Industry payments across ID — which companies pay providers there.
